Skip to search formSkip to main contentSkip to account menu

Sabril

Known as: Sabrilex 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
One year after the Brazilian Ministry of Health declared a public health emergency because of the large rise in the number of… 
2011
2011
Vigabatrin (Sabril®) is used as a drug of last resort in the treatment of refractory seizures. It is associated with a high risk… 
Review
2010
Review
2010
Recently, the United States Food and Drug Administration approved vigabatrin (Sabril®) for the treatment of adults with… 
Review
2010
Review
2010
Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages… 
2008
2008
Vigabatrin (Sabril) is an antiepileptic drug indicated for the treatment of partial epilepsy, which is only licensed as first… 
2004
2004
PURPOSE A case control study was conducted to assess the effect of Sabril (Vigabatrin), Lamictal (Lamotrigine) and Neurontin… 
1999
1999
1. Summary Epilepsy is one of the most common neurological conditions, with an estimated prevalence of 50 m people worldwide… 
Highly Cited
1995
Highly Cited
1995
Summary Vigabatrin (VGB) prevents seizures by irreversible inhibition of γ‐aminobutyric acid (GABA) transaminase and a resulting…